Methods and materials relating to CD39-like polypeptides
AssigneeHyseq, Inc.
InventorsJohn Ford, Julio J. Mulero, George Yeung
Life of this patent
Estimating the term…
Abstract
The invention provides polynucleotides isolated from cDNA libraries of human fetal liver-spleen and macrophage as well as polypeptides encoded by these polynucleotides and mutants or variants thereof. The polypeptides correspond to a human CD39-like protein. Other aspects of the invention include vectors containing polynucleotides of the invention and related host cells as well a processes for producing CD39-like polypeptides, and antibodies specific for such polypeptides.
Claims11
An isolated CD39L2 polynucleotide variant comprising a nucleotide sequence selected from the group consisting of:
- (a) SEQ ID NO:
- 45, (b) SEQ ID NO:
- 46, (c) SEQ ID NO:
- 47, (d) SEQ ID NO:
- 48, (e) SEQ ID NO:
- 49, (f) SEQ ID NO:
- 50, (g) SEQ ID NO:
- 51, (h) SEQ ID NO:
- 53, (i) SEQ ID NO:
- 54, and (j) protein coding portions of (a) through (i).
An isolated CD39L2 polynucleotide variant comprising a nucleotide sequence of SEQ ID NO:
- 47 or a protein coding portion thereof.
Dependencies are inferred from the claim text.